Literature DB >> 4143726

Effects of anti-inflammatory drugs on lymphocytes.

I J Forbes, J L Smith.   

Abstract

Mesh:

Substances:

Year:  1967        PMID: 4143726     DOI: 10.1016/s0140-6736(67)90173-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Effect of analogs of cinanserin on human lymphocytes in vitro.

Authors:  R J Wojnar; D V Myers; R C Millonig; S Rahman; M A Spahn; S M Hess
Journal:  Agents Actions       Date:  1973-11

2.  Abnormal yolk sac function induced by chlorambucil.

Authors:  M M Kernis
Journal:  Experientia       Date:  1971

3.  [In vitro study on the pathogenesis of primary chronic polyarthritis employing the lymphocyte transformation test].

Authors:  W Rothenberger; H G Thiele
Journal:  Klin Wochenschr       Date:  1970-05-01

4.  The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro.

Authors:  L M Pachman; N B Esterly; R D Peterson
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

5.  Lymphocyte transformation in malnourished children.

Authors:  E Sellmeyer; E Bhettay; A S Truswell; O L Meyers; J D Hansen
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

6.  Effects of acetylsalicylic acid on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine.

Authors:  R S Panush; C R Anthony
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

7.  In vivo and in vitro action of chloroquine on surface markers of human peripheral lymphocytes.

Authors:  P S Nagarkatti; M Nagarkatti; V C Jain
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

8.  Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

Authors:  S M Cross; R A Hazelton
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.